Wednesday Mar 29, 2023

FDA Approves Chiesi’s Lamzede® (velmanase alfa-tycv) for Alpha-Mannosidosis Treatement in USA

According to Biospace, the U.S. Food and Drug Administration (FDA) has authorized Lamzede® (velmanase alfa-tycv) for the management of alpha-mannosidosis (AM) in both adult and pediatric patients with non-central nervous system symptoms. This news was made public by Chiesi Global Rare Diseases, a division of Chiesi Farmaceutici S.p.A., a global healthcare group with a research-focused […]

In a Move Away from Cigarettes Philip Morris Recruits FDA Veteran

Philip Morris has named Keagan Leniham who is a former government, corporate and public policymaker as the head of its Washington D.C. office. This is one of Philp Morris’s moves away from tobacco business. She has been appointed as the vice president of government affairs. She will join from Altoida, which is a medical device […]

Back to Top